Who is Dr. Donaldson, Radiation Oncologist in Stanford, CA?
Dr. Sarah Donaldson, MD is a Radiation Oncologist, who primarily practices in Stanford, CA with 1 additional practice location. She is board certified. Dr. Donaldson graduated from Harvard Medical School, Boston, Massachusetts and completed her residency at Stanford University Medical Center. Dr. Donaldson is fluent in English and Spanish, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Donaldson’s office at (650) 723-4000.
Where did Dr. Donaldson go to medical school and complete their residency?
Fellowship: Institut Gustave-Roussy, France
Residency: Stanford University Medical Center | Stanford University Program
Medical School: Harvard Medical School, Boston, Massachusetts
Is Dr. Donaldson board certified as a Radiation Oncologist?
Yes, Dr. Sarah Donaldson, MD is board certified by the American Board of Radiology since 1974
What languages does Dr. Donaldson speak?
Dr. Donaldson and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does a Radiation Oncologist like Dr. Donaldson typically treat?
As a Radiation Oncologist, Dr. Donaldson diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Donaldson. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Generalized Muscle Weakness
- Muscle Disorder
- Overall Body Weakness
- Widespread Muscle Weakness
- Systemic Muscle Weakness
ICD-10 Codes:
- M6281: Muscle weakness (generalized)
What procedures does a Radiation Oncologist like Dr. Donaldson typically perform?
As a Radiation Oncologist, procedures performed by Dr. Sarah Donaldson may include:
- Abdominal Aortic Aneurysm (AAA) Screening
- Abdominal Imaging
- Abdominal Radiology Consultation
- Angiography
- Arthrography
- Barium Swallow
- Bone Biopsy
- Bone Density Measurement / DXA Scan
Please contact Dr. Donaldson's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Donaldson accept my insurance?
Please contact Dr. Donaldson's office to confirm accepted insurance plans.
Where is Dr. Donaldson's office located?
Recognitions
Publications
Low-Dose Radiation Therapy (2 Gy x 2) in the Treatment of Orbital Lymphoma
, 2013
Low-dose radiation therapy (2 Gy × 2) in the treatment of orbital lymphoma.
, 2013
Risk of Salivary Gland Cancer After Childhood Cancer
, 2013
Absolute Risk Prediction of Second Primary Thyroid Cancer Among 5
, 2013
Finding the Balance in Pediatric Hodgkin's Lymphoma
, 2012
Association Between Radiotherapy vs No Radiotherapy Based on Early Response to VAMP Chemotherapy
, 2012
Local Control With Reduced-Dose Radiotherapy for Low-Risk Rhabdomyosarcoma
, 2012
A Tribute to Malcolm A. Bagshaw-An Innovative Physician Who Soared to Success
, 2012
EFFECT OF RADIOTHERAPY TECHNIQUES
, 2012
Risk Factors for Obesity in Adult Survivors of Childhood Cancer
, 2012
REGIOL NODAL INVOLVEMENT AND PATTERNS OF SPREAD ALONG IN
, 2011
Local Control and Outcome in Children With Localized Vagil Rhabdomyosarcoma
, 2011
INFLUENCE OF NONCOMPLIANCE WITH RADIATION THERAPY PROTOCOL GUIDELINES
, 2011
LOCAL THERAPY FOR RHABDOMYOSARCOMA OF THE HANDS AND FEET
, 2011
Prognostic Significance
, 2011
Early Treatment Failure in Intermediate-Risk Rhabdomyosarcoma
, 2010
Subsequent Neoplasms in 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor Study
, 2010
Second Malignt Neoplasms in Survivors of Pediatric Hodgkin's Lymphoma Treated With Low
, 2010
Fertility of Male Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study
, 2010
Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer
, 2009
Neurocognitive Status in Long-Term Survivors of Childhood CNS Maligncies
, 2009
Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and
, 2009
EXTERL BEAM RADIATION THERAPY ENHANCES LOCAL CONTROL IN PIGMENTED VILLONODULAR SYNOVITIS
, 2009
Radiation Dose and Breast Cancer Risk in the Childhood Cancer Survivor Study
, 2009
Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Maligncies in the
, 2009
Fertility of Female Survivors of Childhood Cancer
, 2009
The Childhood Cancer Survivor Study
, 2009
Second Neoplasms in Survivors of Childhood Cancer
, 2009
High-Risk Populations Identified in Childhood Cancer Survivor Study Investigations
, 2009
Medical care in long-term survivors of childhood cancer
, 2008
Understanding the risk of second malignt tumors in children with Hodgkin's disease
, 2008
Fil results of a prospective clinical trial with VAMP
, 2007
New primary neoplasms of the central nervous system in survivors of childhood cancer
, 2006
Female survivors of childhood cancer: Preterm birth and low birth weight among their children
, 2006
Local control in pelvic Ewing sarcoma
, 2006
Advances toward an understanding of brainstem gliomas
, 2006
Stroke as a late treatment effect of Hodgkin's disease
, 2005
Characteristics and outcomes of rhabdomyosarcoma patients with isolated lung metastases from IRS-IV
, 2005
Risk-adapted, combined-modality therapy with VAMP
, 2004
Genetic effects of radiotherapy for childhood cancer: Godal dose reconstruction
, 2004
Influence of radiation therapy parameters on outcome
, 2004
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone
, 2004
Subspecialty training and certification for radiation oncology.
, 2004
Does bladder preservation (as a surgical principle) lead to retaining bladder function in bladder
, 2004
High-dose Therapy and Autologous Hemapoietic Stem
, 2004
Influence of Radiation Therapy Parameters on Outcome
, 2004
Failure Pattern and Factors Predictive of Local Failure in Rhabdomyosarcoma
, 2004
Genetic Effects of Radiotherapy for Childhood Cancer: Godal Dose Reconstruction
, 2004
Risk-adapted Combined-modality Therapy with VAMP
, 2004
Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor
, 2003
Outcome and local control (LC) for bladder prostate rhabdomyosarcoma (BP RMS) on IRS IV
, 2003
Addition of ifosfamide and etoposide to standard chemotherapy
, 2003
Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma
, 2003
Prognostic factors and clinical outcomes
, 2003
Prognostic Factors for Children with Hodgkin's Disease Treated with a Combined Modality Therapy
, 2003
Pediatric Hodgkin's disease - Up, up, and beyond
, 2002
Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose
, 2002
Pediatric Hodgkin's Disease: Up, Up and Beyond
, 2002
VAMP and Low-dose, Involved-field Radiation for Children and Adolescents with Favorable
, 2002
Study Design and Cohort Characteristics of the Childhood Cancer Survivor Study
, 2002
Results from the IRS-IV r
, 2001
Which patients with microscopic disease
, 2001
Controversies in the magement of paratesticular rhabdomyosarcoma
, 2001
Intergroup rhabdomyosarcoma study-IV: Results for patients with nonmetastatic disease
, 2001
Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric met
, 2001
Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life
, 2001
Results from the IRS IV R
, 2001
Second Malignt Neoplasms in Five-Year Survivors of Childhood Cancer
, 2001
Relapse after treatment of pediatric hodgkin lymphoma
, 2013
Low-Dose Radiation Therapy (2 Gy x 2) in the Treatment of Orbital Lymphoma
, 2013
Low-dose radiation therapy (2 Gy × 2) in the treatment of orbital lymphoma.
, 2013
Changes in health status among aging survivors of pediatric upper and lower extremity sarcoma
, 2013
Risk of Salivary Gland Cancer After Childhood Cancer
, 2013
Absolute Risk Prediction of Second Primary Thyroid Cancer Among 5
, 2013
Finding the Balance in Pediatric Hodgkin's Lymphoma
, 2012
Association Between Radiotherapy vs No Radiotherapy Based on Early Response to VAMP Chemotherapy
, 2012
Local Control With Reduced-Dose Radiotherapy for Low-Risk Rhabdomyosarcoma
, 2012
A Tribute to Malcolm A. Bagshaw-An Innovative Physician Who Soared to Success
, 2012
EFFECT OF RADIOTHERAPY TECHNIQUES
, 2012
Risk Factors for Obesity in Adult Survivors of Childhood Cancer
, 2012
Chemotherapy and Thyroid Cancer Risk: a Report from the Childhood Cancer Survivor Study
, 2012
Resectable pediatric nonrhabdomyosarcoma soft tissue sarcoma
, 2012
Controversies in radiotherapy for pediatric Hodgkin's lymphoma
, 2011
Rhabdomyosarcoma in Infants Younger Than 1 Year A Report From the Children's Oncology Group
, 2011
REGIONAL NODAL INVOLVEMENT AND PATTERNS OF SPREAD ALONG IN
, 2011
Local Control and Outcome in Children With Localized Vaginal Rhabdomyosarcoma
, 2011
INFLUENCE OF NONCOMPLIANCE WITH RADIATION THERAPY PROTOCOL GUIDELINES
, 2011
Decreased fertility among female childhood cancer survivors who received 22-27 Gy hypothalamic
, 2011
LOCAL THERAPY FOR RHABDOMYOSARCOMA OF THE HANDS AND FEET
, 2011
Prognostic Significance
, 2011
Risk of Second Primary Thyroid Cancer after Radiotherapy for a Childhood Cancer
, 2010
Treatment Results for Patients With Localized
, 2010
Randomized Phase II Window Trial of Two Schedules of Irinotecan With Vincristine in Patients With
, 2010
Early Treatment Failure in Intermediate-Risk Rhabdomyosarcoma
, 2010
Subsequent Neoplasms in 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor Study
, 2010
Second Malignant Neoplasms in Survivors of Pediatric Hodgkin's Lymphoma Treated With Low
, 2010
Fertility of Male Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study
, 2010
Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer
, 2009
Neurocognitive Status in Long-Term Survivors of Childhood CNS Malignancies
, 2009
Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and
, 2009
EXTERNAL BEAM RADIATION THERAPY ENHANCES LOCAL CONTROL IN PIGMENTED VILLONODULAR SYNOVITIS
, 2009
Radiation Dose and Breast Cancer Risk in the Childhood Cancer Survivor Study
, 2009
Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Malignancies in the
, 2009
Fertility of Female Survivors of Childhood Cancer
, 2009
The Childhood Cancer Survivor Study
, 2009
Second Neoplasms in Survivors of Childhood Cancer
, 2009
High-Risk Populations Identified in Childhood Cancer Survivor Study Investigations
, 2009
Medical care in long-term survivors of childhood cancer
, 2008
Understanding the risk of second malignant tumors in children with Hodgkin's disease
, 2008
Results in patients with cranial parameningeal sarcoma and metastases
, 2008
Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma
, 2008
Treatment of Pediatric Hodgkin Lymphoma
, 2008
Treatment of metastatuc Ewing Sarcoma
, 2007
Final results of a prospective clinical trial with VAMP
, 2007
New primary neoplasms of the central nervous system in survivors of childhood cancer
, 2006
Female survivors of childhood cancer: Preterm birth and low birth weight among their children
, 2006
Thyroid cancer in childhood cancer survivors
, 2006
Local control in pelvic Ewing sarcoma
, 2006
Advances toward an understanding of brainstem gliomas
, 2006
Stroke as a late treatment effect of Hodgkin's disease
, 2005
Long-term medical effects of childhood and adolescent rhabdomyosarcoma
, 2005
Characteristics and outcomes of rhabdomyosarcoma patients with isolated lung metastases from IRS-IV
, 2005
Risk-adapted, combined-modality therapy with VAMP
, 2004
Genetic effects of radiotherapy for childhood cancer: Gonadal dose reconstruction
, 2004
Cyclophosphamide dose intensification during induction therapy for intermediate
, 2004
Influence of radiation therapy parameters on outcome
, 2004
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone
, 2004
Subspecialty training and certification for radiation oncology.
, 2004
Results of treatment of fifty-six patients with localized retroperitoneal
, 2004
Does bladder preservation (as a surgical principle) lead to retaining bladder function in bladder
, 2004
Ewing sarcoma: radiation dose and target volume.
, 2004
High-dose Therapy and Autologous Hemapoietic Stem
, 2004
Influence of Radiation Therapy Parameters on Outcome
, 2004
Failure Pattern and Factors Predictive of Local Failure in Rhabdomyosarcoma
, 2004
Genetic Effects of Radiotherapy for Childhood Cancer: Gonadal Dose Reconstruction
, 2004
Risk-adapted Combined-modality Therapy with VAMP
, 2004
Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor
, 2003
Outcome and local control (LC) for bladder prostate rhabdomyosarcoma (BP RMS) on IRS IV
, 2003
Addition of ifosfamide and etoposide to standard chemotherapy
, 2003
Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma
, 2003
A discourse: The 2002 Wataru W. Sutow Lecture - Hodgkin disease in children
, 2003
Prognostic factors and clinical outcomes
, 2003
Genetic Effects of Radiotherapy for Childhood Cancer
, 2003
Prognostic Factors for Children with Hodgkin's Disease Treated with a Combined Modality Therapy
, 2003
A Discourse: The 2002 Wataru W. Sutow Lecture; Hodgkin's Disease in Children
, 2003
Pediatric Hodgkin's disease - Up, up, and beyond
, 2002
Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose
, 2002
Pediatric Hodgkin's Disease: Up, Up and Beyond
, 2002
VAMP and Low-dose, Involved-field Radiation for Children and Adolescents with Favorable
, 2002
Study Design and Cohort Characteristics of the Childhood Cancer Survivor Study
, 2002
Rhabdomyosarcoma of the parotid region occurring in childhood
, 2001
Results from the IRS-IV r
, 2001
Long-term results of irradiation for patients with progressive Graves' ophthalmopathy
, 2001
Which patients with microscopic disease
, 2001
Controversies in the management of paratesticular rhabdomyosarcoma
, 2001
Intergroup rhabdomyosarcoma study-IV: Results for patients with nonmetastatic disease
, 2001
Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric met
, 2001
Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life
, 2001
The Intergroup Rhabdomyosarcoma Study Group (IRSG)
, 2001
Results from the IRS IV R
, 2001
Second Malignant Neoplasms in Five-Year Survivors of Childhood Cancer
, 2001
Long-term Results of Irradiati
What is Dr. Donaldson's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Donaldson's National Provider Identifier (NPI) number is 1033276316.
What common questions do patients ask about Dr. Donaldson?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Donaldson
What is Dr. Sarah Donaldson's specialty?
Dr. Donaldson is a Radiation Oncologist near Stanford, CA.
What does a Radiation Oncologist do?
A radiological oncologist specializes in the therapeutic applications of radiant energy and its modifiers. They focus on the study and management of diseases, particularly malignant tumors.
Is this Dr. Sarah Donaldson affiliated with a ranked Castle Connolly Top Hospital?
No, Donaldson is not affiliated with a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see a Radiation Oncologist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see a Radiation Oncologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Sarah Donaldson accepting new patients in Stanford, CA?
Yes, Dr. Sarah Donaldson is accepting new patients at this time.
Does Dr. Sarah Donaldson offer online booking?
Please contact Dr. Donaldson's office at (650) 723-4000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Sarah Donaldson?
Please contact Dr. Donaldson's office at (650) 723-4000 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Sarah Donaldson have?
Dr. Sarah Donaldson is certified by the American Board of Radiology.
Other Radiation Oncologist Near Stanford, CA
Radiation Oncologist
Accepting patients
Radiation Oncologist
Accepting patients
Radiation Oncologist
Accepting patients